Brands
Discover
Events
Newsletter
More

Follow Us

twitterfacebookinstagramyoutube
ADVERTISEMENT
Advertise with us

A global pharma empire built out of Pune

Pune-based Emcure Pharma has built a presence in 70 countries since 1981. The promoters continue to own 86 percent equity in the Bain Capital-backed firm. Founder Satish Mehta traces the four-decade journey of the homegrown pharma major.

A global pharma empire built out of Pune

Friday August 20, 2021 , 4 min Read

Good Morning,


Second-generation entrepreneur Satish Mehta started Emcure Pharmaceuticals decades before ‘Made in India’ or ‘Build in India’ became catchphrases. Driven by the urge to do something on his own, he took a bank loan of Rs 3 lakh and launched Emcure in 1981. 


The Pune-based firm went on to develop and sell its own branded generic formulations across 70 countries, and become one of the leading companies in the sector. 


In a conversation with Shradha Sharma, Founder and CEO of YourStory, he says, “Data says we are amongst the top 10 [pharma companies in India]. But, I'm not happy. I would like to take the company to the top five. That’s the driving force.”


The Emcure MD goes on to say,


“This year, we will do Rs 7,000 crore [of business], but at the same time, you think ‘somebody is doing Rs 30,000 crore’. There is always a desire to do better than what you've done yesterday.”

emcure pharma

Emcure Pharma Founder & MD Satish Mehta in conversation with YourStory Founder and CEO Shradha Sharma

Over the last 40 years, Emcure has built a network of 19 subsidiaries, an R&D team of 500 scientists, and a global workforce of 11,000 people. Its lifetime revenues are touching Rs 7,000 crore, with only 44 percent of it coming from the domestic market. 


Turning a Rs 3 lakh investment into a billion-dollar enterprise sure required a lot of chutzpah. Add to that, Satish’s own swelling fortune.


In 2016, Satish was ranked as the 82nd richest Indian with a net worth of $1.6 billion, on the Forbes Rich List. 


Having registered a 15 percent topline growth in H1 2021, Emcure now is gearing up for a Rs 4,000 crore IPO, and is betting big on mRNA vaccines for COVID-19.



The Interview

In 2018, Zomato shared that chicken biryani was the most ordered item. In 2019, Swiggy reported that Indians ordered an average of 95 biryanis per minute.


Started as a small cloud kitchen in Gurugram, Biryani by Kilo is spread across 50 outlets in 20 cities of India. Founder and CEO Kaushik Roy tells how the food chain was able to create a Biryani revolution.



Editor’s Pick: App Fridays

A digital reading platform for kids, Epic is regularly used by two million teachers and over 50 million kids. It is present across 90 percent of the schools in the US, with its growth propelled by the pandemic.


Recently, the California-based startup was acquired by edtech decacorn BYJU'S for $500 million in one of the largest international M&As carried out by an Indian company. Read more.

epic logo



Startup Spotlight

Helping India fight COVID-19


Amid the COVID-19 pandemic, many sectors pivoted to survive and also aid India’s battle against the pandemic.


Founded in 2017 by IIT Kanpur alumni Harshit Rathore and Nikhil Kurele as a solar panel cleaning robots manufacturer, Pune-based Noccarc pivoted to building ventilators to support the country in its fight against COVID-19. Read more.

Noccarc Founders



News & Updates






Before you go, stay inspired with… 

Satish Mehta Emcure Pharma
“I’ve never felt that I'm the owner of the company. I come here as the chief executive, as the first among equals.”

Satish Mehta, Founder and MD, Emcure Pharma



Now get the Daily Capsule in your inbox. Subscribe to our newsletter today!


Edited by Kanishk Singh